|
Volumn 52, Issue 1, 2012, Pages 77-79
|
Retrospective study of the utility of FLIPI/FLIPI-2 for follicular lymphoma patients treated with R-CHOP.
a a a a a a a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
MONOCLONAL ANTIBODY;
PREDNISONE;
R CHOP PROTOCOL;
R-CHOP PROTOCOL;
VINCRISTINE;
ADULT;
AGED;
CLINICAL TRIAL;
COMPARATIVE STUDY;
DISEASE FREE SURVIVAL;
FEMALE;
FOLLICULAR LYMPHOMA;
HUMAN;
LETTER;
MALE;
MIDDLE AGED;
MORTALITY;
RETROSPECTIVE STUDY;
SURVIVAL RATE;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL, MURINE-DERIVED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYCLOPHOSPHAMIDE;
DISEASE-FREE SURVIVAL;
DOXORUBICIN;
FEMALE;
HUMANS;
LYMPHOMA, FOLLICULAR;
MALE;
MIDDLE AGED;
PREDNISONE;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
VINCRISTINE;
|
EID: 84867621986
PISSN: None
EISSN: 18809952
Source Type: Journal
DOI: 10.3960/jslrt.52.77 Document Type: Letter |
Times cited : (6)
|
References (0)
|